Skip to main content
logo
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
25.78
-0.30 (-1.15%)
Mar 12, 2026, 1:22 PM EDT - Market open

Beam Therapeutics Revenue

In the year 2025, Beam Therapeutics had annual revenue of $139.74M with 120.01% growth. Beam Therapeutics had revenue of $114.11M in the quarter ending December 31, 2025, with 279.52% growth.

Revenue (ttm)
$139.74M
Revenue Growth
+120.01%
P/S Ratio
17.91
Revenue / Employee
$273,470
Employees
511
Market Cap
2.56B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025139.74M76.23M120.01%
Dec 31, 202463.52M-314.19M-83.18%
Dec 31, 2023377.71M316.79M520.01%
Dec 31, 202260.92M9.08M17.51%
Dec 31, 202151.84M51.82M215,916.67%
Dec 31, 202024.00K6.00K33.33%
Dec 31, 201918.00K--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Apellis Pharmaceuticals1.00B
Catalyst Pharmaceuticals588.99M
Travere Therapeutics490.73M
Arcutis Biotherapeutics376.07M
Arcus Biosciences247.00M
Viridian Therapeutics70.85M
Wave Life Sciences42.73M
Revenue Rankings

BEAM News

More News